nice randomized trial showing no significant difference in major clinical outcomes (good or bad) with addition of multiple very low dose memory t cell dli to tcrab-depleted haplohct. what is the best cd45-neg t-cell dose/timing?➡️still unclear! https://t.co/9wukbo9tuu